2017
DOI: 10.1111/bcp.13383
|View full text |Cite
|
Sign up to set email alerts
|

FXa inhibition by rivaroxaban modifies mechanisms associated with the pathogenesis of human abdominal aortic aneurysms

Abstract: FXa inhibition by rivaroxaban exerted anti-inflammatory and antioxidative stress properties in human AAA sites, suggesting a role of FXa in these mechanisms associated with the pathogenesis of AAA.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
27
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(28 citation statements)
references
References 51 publications
1
27
0
Order By: Relevance
“…The gels were blotted onto nitrocellulose (NC) membranes. As previously reported (Zamorano-León et al, 2013; Moñux et al, 2017), NC membranes were blocked with 5% (w/v) bovine serum albumin (BSA) and incubated with monoclonal antibodies against Mfn-1 (1:2,000, sc-166644, Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), Mfn-2 (1:1,000, sc-2031, Santa Cruz Biotechnology, Inc.), Drp-1 (1:750, Ab56788, Abcam, Cambridge, UK), and B-cell lymphoma 2 (Bcl-2)-antagonist/killer (Bak) (1:1,000, Ab32371, Abcam), and polyclonal antibodies against p53 (1:1,000, sc-6243, Santa Cruz Biotechnology, Inc.), cyclin B1 (1:1,500, Ab2949, Abcam), Bcl-2-associated X protein (Bax) (1:1,000, sc-493, Santa Cruz Biotechnology, Inc.), and Bcl-2 (1:1,000, sc-783, Santa Cruz Biotechnology, Inc.). A monoclonal anti-β-actin antibody (1:7,500, A-5441, Sigma-Aldrich Co.) was used as a control for protein loading.…”
Section: Methodssupporting
confidence: 85%
See 1 more Smart Citation
“…The gels were blotted onto nitrocellulose (NC) membranes. As previously reported (Zamorano-León et al, 2013; Moñux et al, 2017), NC membranes were blocked with 5% (w/v) bovine serum albumin (BSA) and incubated with monoclonal antibodies against Mfn-1 (1:2,000, sc-166644, Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), Mfn-2 (1:1,000, sc-2031, Santa Cruz Biotechnology, Inc.), Drp-1 (1:750, Ab56788, Abcam, Cambridge, UK), and B-cell lymphoma 2 (Bcl-2)-antagonist/killer (Bak) (1:1,000, Ab32371, Abcam), and polyclonal antibodies against p53 (1:1,000, sc-6243, Santa Cruz Biotechnology, Inc.), cyclin B1 (1:1,500, Ab2949, Abcam), Bcl-2-associated X protein (Bax) (1:1,000, sc-493, Santa Cruz Biotechnology, Inc.), and Bcl-2 (1:1,000, sc-783, Santa Cruz Biotechnology, Inc.). A monoclonal anti-β-actin antibody (1:7,500, A-5441, Sigma-Aldrich Co.) was used as a control for protein loading.…”
Section: Methodssupporting
confidence: 85%
“…Protein expression was determined by Western blotting. In brief, and as we have previously reported (Zamorano-León et al, 2013; Moñux et al, 2017), protein concentrations were estimated using the bicinchoninic acid reagent (Thermo Fisher Scientific, Inc., Waltham, MA, USA), and equal amount (40 μg/lane) of each lysate were loaded onto denaturing sodium dodecyl sulphate-polyacrylamide gel electrophoresis 15% (w/v) polyacrylamide gels. The gels were blotted onto nitrocellulose (NC) membranes.…”
Section: Methodsmentioning
confidence: 99%
“…These findings indicate a probable role for FXa in the pathogenesis of aneurysms. Perhaps, a better understanding of the role of FXa in aneurysms in the future may create new opportunities and possibilities for the use of direct FXa inhibitors [12].…”
Section: Discussionmentioning
confidence: 99%
“…Activated MMP-9 in particularly is thought to be both cause and biomarker of fibrotic remodeling predisposing to arrhythmias [66][67][68][69]. Thrombin and FXa both regulate MMP-9 expression and activity [70][71][72][73][74][75] while DOAC treatment reduces MMP-9 levels [76][77][78], which may be one means by which DOAC could limit the structural changes that support AF maintenance. Fibrotically remodeled atrial tissue is characterized by excess collagen that compromises impulse propagation that supports arrhythmia development [79][80][81].…”
Section: Inhibition Of the Fibro-inflammatory Substrate Supporting Afmentioning
confidence: 99%